Year: 2022
Type: dissertation
Abstract: Stress-related disorders such as depression and PTSD affect millions of people every year. However, clinical interventions remain variable in their efficacy. Ketamine, an NMDA receptor antagonist, is a newly proposed treatment of stress-related disorders. Ketamine reduces burst firing in the lateral habenula (LHb), a critical brain region in the integration of aversive stimuli. Here, I monitored how neurochemical signaling to LHb neurons changed during a stressor controllability paradigm and how ketamine directly modified signaling dynamics and stress-related behavior. To assess the efficacy of ketamine pretreatment on behavioral stress resilience, mice were given ketamine or saline seven days before either an inescapable stressor (IS) or escapable stressor (ES). Generalized fear behavior was monitored via freezing in a novel context. Mice treated with ketamine seven days before an IS session exhibited significantly less freezing behavior in post tests compared to the saline control group. I expressed a fluorescent biosensor (iGluSnFR) in LHb glutamate neurons to record glutamate signaling during IS or ES seven days after either saline or ketamine injections. IS mice pre-treated with ketamine had reduced iGluSnFR signaling during the last 20 shock trials compared to the first 20 trials out of 100 and reduced signaling in the last 20 trials compared to saline pre-treated mice. Together, these results indicate that ketamine pre- treatment modulates stress circuitry via differential LHb glutamate signaling and has a long-term protective effect on stress-related behavior.
Author: Plantz, William
Institution: University of Colorado Boulder
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6986653647
